Boston Scientific to acquire Remon Medical Technologies
3 July 2007
Natick, Mass., USA. Boston Scientific Corporation
(NYSE:BSX) is to acquire private Israeli company Remon Medical Technologies
Inc. Remon develops minute smart devices for implanting in the body that can
monitor physiological parameters, stimulate tissues or organs, or activate
other devices that deliver drugs and communicate wirelessly. Terms of the
acquisition were not disclosed.
The technology has potential applications in patient management,
post-operative monitoring, nerve and tissue stimulation, local drug
delivery, and drug development.
The company was founded in 1997, with
several senior managers from Medtronic Israel. It entered into a
co-development agreement with Guidant Corporation in 2004, and Guidant
itself was acquired by Boston Scientific in 2006.
Remon's first two
products consist of a device to monitor the haemodynamic status of patients
with congestive heart failure (CHF) and a device to monitor pressure
following an endograft procedure in abdominal aortic aneurysm (AAA)
"Remon Medical Technologies brings to Boston Scientific innovative sensor
and wireless communication technology to Boston Scientific, which
complements our Cardiac Rhythm Management product line," said Fred Colen,
Executive Vice President, Operations and Technology, CRM, and Chief
Technology Officer. "This acquisition reflects our commitment to being a
leader in the CRM market through the introduction of innovative products and
services for the benefit of physicians and their patients."
"We've spent the last several years developing smart, miniature implants
designed to enable physicians to assess and treat a variety of medical
conditions in a non-invasive manner," said Hezi Himelfarb, Remon Medical
Technologies, Inc.'s Chief Executive Officer. "The acquisition by Boston
Scientific will position Remon as a recognized leader in intra-body wireless
communication and help realize the potential of our technology, once
integrated into the portfolio of Boston Scientific products."